S. Korea Scientists Develop Flu Vaccine Delivered Under Tongue
This article was originally published in PharmAsia News
Executive Summary
Medical researchers in South Korea report success in providing a vaccination with a pill under the tongue instead of using a needle, or ingesting or inhaling the drug. The research team at the International Vaccine Institute in Seoul tested a flu vaccine on mice and said they developed a healthy immune response in their lungs and repelled a more severe form of the virus later. The leading researcher said the method eliminates a risk of an antigen redirection to the central nervous system, a risk common to vaccines delivered intravenously. (Click here for more
You may also be interested in...
Warning Letter Roundup & Recap – 1 December 2020
In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.
On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions
A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.
EU Health Ministers To Deliberate Over Commission’s Pharma Strategy
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Need a specific report? 1000+ reports available
Buy Reports